Published in Biochim Biophys Acta on July 13, 1971
Activation of high levels of endogenous phospholipase A2 in cultured cells. Proc Natl Acad Sci U S A (1979) 1.37
Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med (1993) 7.67
Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut (2005) 2.38
Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial. Endoscopy (1998) 1.83
Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. I. Target cells and possible mode of action. Eur J Immunol (1973) 1.80
Significance of phospholipase A for prostaglandin formation. Ann N Y Acad Sci (1971) 1.59
Skin signs in acute pancreatitis: frequency and implications for prognosis. J Intern Med (2009) 1.58
Steatorrhoea: you cannot trust your eyes when it comes to diagnosis. Lancet (1996) 1.54
[Pantoprazole-induced hepatitis]. Dtsch Med Wochenschr (2003) 1.51
Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Dig Dis Sci (1983) 1.46
Gallstone ileus: endoscopic removal of a gallstone obstructing the upper jejunum. J Intern Med (1999) 1.43
Performance of various mathematical methods for computer-aided processing of radioimmunoassay results. Clin Chim Acta (1978) 1.40
Hirsutism-skeletal dysplasia-mental retardation syndrome with abnormal face and a uric acid metabolism disorder. Am J Med Genet (1993) 1.39
Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement. Hoppe Seylers Z Physiol Chem (1974) 1.29
The influence of glucagon on acute experimental pancreatitis in the rat. Scand J Gastroenterol (1974) 1.26
Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group. Am J Gastroenterol (1994) 1.24
Stimulation of B-cells by dextran sulphate in vitro. Immunology (1973) 1.23
Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut (1997) 1.23
Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b. Scand J Immunol (1981) 1.22
A new function of the activated third component of complement: binding to C5, an essential step for C5 activation. Immunology (1978) 1.20
Complement activation by the properdin system: formation of a stoichiometric. C3 cleaving complex of properdin factor B with C36. Immunochemistry (1977) 1.19
Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol Clin North Am (1999) 1.14
Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose. Z Immunitatsforsch Exp Klin Immunol (1975) 1.14
Prostaglandin release from and formation in perfused frog intestine. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 1.13
Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. II. Relationship between adjuvant activity and stimulation of DNA synthesis by polyanions. Eur J Immunol (1973) 1.12
Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency? Gastroenterology (1986) 1.12
Exocrine pancreatic function tests. Gut (1982) 1.12
Diagnosis of porphyrias by ion-pair high-performance liquid chromatography. J Chromatogr (1980) 1.12
Somatostatin and the gastrointestinal tract. Clin Gastroenterol (1980) 1.12
Contraction of the guinea-pig ileum induced by anaphylatoxin independent of histamine release. Int Arch Allergy Appl Immunol (1970) 1.10
Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a. Hoppe Seylers Z Physiol Chem (1980) 1.09
Effects of local anaesthetics on prostaglandin biosynthesis in vitro. Biochim Biophys Acta (1974) 1.09
Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology (2001) 1.06
Continuous peritoneal dialysis as treatment of acute experimental pancreatitis in the rat. I. Effect on length and rate of survival. Dig Dis Sci (1979) 1.06
Actions of anaphylatoxin on circulation and respiration of the guinea pig. Int Arch Allergy Appl Immunol (1967) 1.06
Biological activities of C5a and C5adesArg from hog serum. Int Arch Allergy Appl Immunol (1980) 1.05
Activation, activities and pharmacologically active products of complement. Pharmacol Rev (1974) 1.05
[Pancreolauryl test compared to NBT-PABA test. Screening test for diagnosis of exocrine pancreatic insufficiency?]. Dtsch Med Wochenschr (1980) 1.04
Induction of platelet aggregation by the complement-derived peptides C3a and C5a. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.04
Purification and some properties of factor D of the human properdin system. Z Immunitatsforsch Immunobiol (1976) 1.04
Publication rates following pancreas meetings. Pancreas (2001) 1.04
Longitudinal manganese and copper balances in young infants and preterm infants fed on breast-milk and adapted cow's milk formulas. Br J Nutr (1989) 1.03
Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B. Hoppe Seylers Z Physiol Chem (1973) 1.03
Role of phospholipase A2 in prostaglandin formation. Adv Prostaglandin Thromboxane Res (1978) 1.02
[Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)]. Dtsch Med Wochenschr (1975) 1.01
Iron balances in infant nutrition. Acta Paediatr Scand (1987) 1.00
[Formation by phospholipase A of SRS-C in perfused guinea pig lung. Identification with prostaglandin]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.99
Antinuclear and pancreatic acinar cell antibodies in pancreatic diseases. Digestion (1981) 0.98
Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion (1982) 0.97
Tubeless pancreatic function tests. Hepatogastroenterology (1981) 0.96
Anaphylatoxins: possible roles in disease. Complement (1986) 0.96
Purification of a human serum protein ("factor E") which enhances cobra venom factor-induced indirect lysis. Identification with the fifth component of complement. Z Immunitatsforsch Exp Klin Immunol (1976) 0.96
Prostaglandin: liberation from and formation in perfused frog intestine. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.96
Preparation and some properties of anaphylatoxin from hog serum. Biochem Pharmacol (1968) 0.95
[Effect of somatostatin on betazole-stimulated gastric secretion and carbachol-stimulated pancreatic secretion and gall bladder contraction in man(author's transl)]. Dtsch Med Wochenschr (1975) 0.95
Functional identity of anaphylatoxin preparations obtained from different sources and by different activation procedures. 1. Pharmacological experiments. Eur J Pharmacol (1970) 0.95
Pulmonary complications in fatal acute hemorrhagic pancreatitis. Dig Dis Sci (1983) 0.95
The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. J Thorac Cardiovasc Surg (1991) 0.94
Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases. Clin Exp Immunol (1975) 0.94
Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three synthetic formyl-methionyl peptides. Int Arch Allergy Appl Immunol (1980) 0.93
Alcohol consumption in patients with acute or chronic pancreatitis. Pancreatology (2007) 0.93
Somatostatin therapy of acute experimental pancreatitis. Gut (1977) 0.93
Effect of L-asparaginase and hydrocortisone on human lymphocyte transformation and production of a mononuclear leucocyte chemotactic factor in vitro. Immunology (1974) 0.93
Multiple effects of a diamidine (propamidine) on complement activation. Immunology (1979) 0.91
Incompatibility between C3b and B of guinea-pig and man and its influence on the titration of the alternative pathway factors D and B in these two species. Immunology (1976) 0.91
Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage. Immunobiology (1980) 0.91
Formation of anaphylatoxin in rat plasma, a specific enzymic process. Biochem Pharmacol (1966) 0.91
Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep (2001) 0.91
Interference of propamidine with binding of the fifth component of complement to surface-fixed C3b, and with C5 activation. Immunology (1979) 0.90
Loss and recovery of sensitivity of guinea-pig isolated ileum to the spasmogenic action of the complement peptide C5adesArg. Br J Pharmacol (1985) 0.89
Use of saliva in monitoring carbamazepine medication in epileptic children. Eur J Pediatr (1977) 0.89
Influence of secretin on the course of acute experimental pancreatitis in rats. Digestion (1983) 0.89
Functional reserve capacity of the exocrine pancreas. Digestion (1986) 0.89
Effects of the cleavage peptides, C3q and C3ai, from the third component of hog complement on leukocyte accumulation and vascular permeability in vivo. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.88
[Is the hyperostotic spondylosis deformans a diabetic osteopathy?]. Fortschr Geb Rontgenstr Nuklearmed (1969) 0.88
Mechanisms of complement activation by crystalline cholesterol. Mol Immunol (1985) 0.88
Complement system in sodium taurocholate pancreatitis in the rat. Res Exp Med (Berl) (1978) 0.88
Acute pancreatitis and hyperamylasaemia in pancreatic carcinoma. Pancreas (1987) 0.88
[Symptomless spontaneous rupture of a pancreatic pseudocyst into the stomach]. Rofo (1989) 0.88
Splenic lesion as a complication of laparoscopy. Case report. Z Gastroenterol (1992) 0.88
Synergism between phospholipase A and various peptides and SH-reagents in causing haemolysis. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.87
Effect of hog anaphylatoxin (C 5a) on vascular permeability and leukocyte emigration in vivo. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.87
Radiological case of the month. Denouement and discussion: congenital esophageal duplication cyst as a rare cause of neonatal progressive stridor. Arch Pediatr Adolesc Med (2001) 0.87
Improved separation and detection of free porphyrins by high-performance liquid chromatography. J Chromatogr (1984) 0.87
The anaphylatoxin-forming system. Ergeb Physiol (1967) 0.87
Group experiments on the radioimmunological insulin determination. Horm Metab Res (1974) 0.86
Trypsin radioimmunoassay in the diagnosis of chronic pancreatitis. Digestion (1980) 0.86
Serum complement factors in human acute pancreatitis. Hepatogastroenterology (1981) 0.86
Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis. Eur J Gastroenterol Hepatol (1998) 0.84
Iron availability from an infant formula supplemented with bovine lactoferrin. Acta Paediatr Scand (1991) 0.84
Release of glutamate and of free fatty acids in vasogenic brain edema. J Neurosurg (1989) 0.84
Use of Tenckhoff catheter for peritoneal dialysis in terminal renal failure. Br Med J (1973) 0.84
Recovery of the pancreas after acute pancreatitis is not necessarily complete. Int J Pancreatol (1995) 0.84
[Separation of an anaphylatoxin-forming principle from other venom components in cobra venom]. Experientia (1964) 0.84
Clinical evaluation of a 25 g D-xylose hydrogen (H2) breath test. Z Gastroenterol (1990) 0.84
Does gastroscopy induce myocardial ischemia in patients with coronary heart disease? Endoscopy (2000) 0.83
Formation of anaphylatoxin in human serum. Experientia (1969) 0.83